Obesity is one of the most important modifiable risk factors for the development of hyperuricemia and gout. Numerous epidemiological studies have demonstrated that increasing body mass index (BMI) is strongly associated with both elevated serum uric acid concentrations and a higher incidence of recurrent gout attacks. The relationship is multifactorial and involves metabolic, renal, hormonal, and inflammatory mechanisms.

Increased Uric Acid Production

Individuals with obesity produce greater amounts of uric acid due to increased purine turnover associated with a larger body mass and expanded adipose tissue. In addition, excessive consumption of purine-rich foods, sugar-sweetened beverages, and foods containing high-fructose corn syrup further increases uric acid production by accelerating hepatic purine metabolism.

Reduced Renal Excretion of Uric Acid

The kidneys are responsible for eliminating approximately two-thirds of the body’s uric acid. In people with obesity, renal uric acid excretion is frequently impaired. Increased tubular reabsorption of urate, reduced glomerular filtration in some individuals, and obesity-related renal dysfunction contribute to elevated serum uric acid concentrations, thereby increasing the risk of monosodium urate crystal formation.

Chronic Low-Grade Inflammation

Obesity is characterized by chronic low-grade systemic inflammation. Adipose tissue secretes numerous pro-inflammatory cytokines and adipokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and leptin. These inflammatory mediators enhance immune activation and facilitate the inflammatory response triggered by monosodium urate crystals deposited within joints, making acute gout attacks more likely.

Insulin Resistance and Metabolic Syndrome

Obesity is closely associated with insulin resistance, metabolic syndrome, and type 2 diabetes mellitus. Hyperinsulinemia decreases renal uric acid excretion, leading to elevated serum urate concentrations (hyperuricemia). Consequently, individuals with insulin resistance have a substantially increased risk of developing gout.

Additional Risk Factors

Several additional factors may contribute to the development of hyperuricemia and gout, including:

• Excessive alcohol consumption, particularly beer and spirits
• Diets rich in purines (e.g., red meat, organ meats, and certain seafood)
• High intake of fructose-containing beverages
• Chronic kidney disease
• Hypertension
• Genetic predisposition affecting urate transport
• Certain medications

Hyperuricemia

Hyperuricemia is defined as a serum uric acid concentration that exceeds the physiological saturation threshold for monosodium urate crystals. Although laboratory reference ranges vary slightly among institutions, commonly used thresholds are:

• Men: >7.0 mg/dL (420 µmol/L)
• Women: >6.0 mg/dL (360 µmol/L)

It is important to note that not every individual with hyperuricemia develops gout, and conversely, gout may occur even when serum uric acid levels are within the normal laboratory range.

Gout with Normal Serum Uric Acid Levels

Normouricemic Gout

Some patients experience acute gout despite having serum uric acid concentrations within the normal range. This occurs because gout is caused by monosodium urate crystals that have already been deposited in the joints. Once crystals are present, they can trigger intense inflammatory reactions regardless of the current serum urate concentration.

Serum Uric Acid During an Acute Gout Attack

During an acute gout flare, serum uric acid levels may appear normal or even temporarily reduced. This phenomenon occurs because circulating uric acid is deposited into inflamed joints, lowering its concentration in the bloodstream. Consequently, measuring serum uric acid during an acute attack may underestimate the patient’s usual urate level. If diagnostic uncertainty exists, serum uric acid should be reassessed several weeks after the acute episode has resolved.

Medications and Comorbidities

Several medications and underlying medical conditions influence serum uric acid levels and the risk of gout.

Medications that may increase serum uric acid concentrations include:

• Thiazide and loop diuretics
• Low-dose aspirin
• Cyclosporine
• Tacrolimus
• Niacin

Conversely, certain medications may lower serum uric acid concentrations, including:

• Losartan
• Fenofibrate
• Sodium-glucose cotransporter-2 (SGLT2) inhibitors

Medical conditions associated with hyperuricemia include:

• Chronic kidney disease
• Hypertension
• Metabolic syndrome
• Type 2 diabetes mellitus
• Heart failure
• Psoriasis
• Hematologic malignancies with increased cell turnover

Clinical Implications

Weight reduction is one of the most effective non-pharmacological interventions for reducing serum uric acid concentrations and lowering the frequency of gout attacks. Even moderate, sustained weight loss has been shown to improve insulin sensitivity, reduce systemic inflammation, enhance renal urate excretion, and decrease the risk of recurrent gout flares. Comprehensive lifestyle modification—including healthy dietary patterns, regular physical activity, adequate hydration, limiting alcohol consumption, and reducing fructose intake—forms an essential component of long-term gout management alongside pharmacological urate-lowering therapy when indicated.